{"id": "RS22814", "inputs": [{"text": "it takes an average of 15 years from the moment a manufacturer first approaches the food and drug administration ( fda ) with an idea for a new drug to its final approval for marketing .", "tokens": ["it", "takes", "an", "average", "of", "15", "years", "from", "the", "moment", "a", "manufacturer", "first", "approaches", "the", "food", "and", "drug", "administration", "(", "fda", ")", "with", "an", "idea", "for", "a", "new", "drug", "to", "its", "final", "approval", "for", "marketing", "."], "sentence_id": 1, "word_count": 36}, {"text": "steps in the development and approval of a drug or biologic ( e.g. , a vaccine ) involve actions by both the manufacturer and fda .", "tokens": ["steps", "in", "the", "development", "and", "approval", "of", "a", "drug", "or", "biologic", "(", "e.g", ".", ",", "a", "vaccine", ")", "involve", "actions", "by", "both", "the", "manufacturer", "and", "fda", "."], "sentence_id": 2, "word_count": 27}, {"text": "first , a manufacturer ( sometimes referred to as the sponsor ) submits to fda an investigational new drug ( ind ) application for permission to conduct clinical studies in humans .", "tokens": ["first", ",", "a", "manufacturer", "(", "sometimes", "referred", "to", "as", "the", "sponsor", ")", "submits", "to", "fda", "an", "investigational", "new", "drug", "(", "ind", ")", "application", "for", "permission", "to", "conduct", "clinical", "studies", "in", "humans", "."], "sentence_id": 3, "word_count": 32}, {"text": "second , the manufacturer completes phase i , ii , and iii clinical trials to establish that a product is safe and effective for a specific purpose and population .", "tokens": ["second", ",", "the", "manufacturer", "completes", "phase", "i", ",", "ii", ",", "and", "iii", "clinical", "trials", "to", "establish", "that", "a", "product", "is", "safe", "and", "effective", "for", "a", "specific", "purpose", "and", "population", "."], "sentence_id": 4, "word_count": 30}, {"text": "third , the manufacturer submits to fda a new drug application or a biologics licensing application ( noted as nda / bla throughout this report ) for permission to market the product .", "tokens": ["third", ",", "the", "manufacturer", "submits", "to", "fda", "a", "new", "drug", "application", "or", "a", "biologics", "licensing", "application", "(", "noted", "as", "nda", "/", "bla", "throughout", "this", "report", ")", "for", "permission", "to", "market", "the", "product", "."], "sentence_id": 5, "word_count": 33}, {"text": "fourth , fda reviews the nda / bla for evidence of safety and effectiveness , a process that sometimes includes requests to the sponsor for additional information , the sponsor's response , and further fda review .", "tokens": ["fourth", ",", "fda", "reviews", "the", "nda", "/", "bla", "for", "evidence", "of", "safety", "and", "effectiveness", ",", "a", "process", "that", "sometimes", "includes", "requests", "to", "the", "sponsor", "for", "additional", "information", ",", "the", "sponsor", "'s", "response", ",", "and", "further", "fda", "review", "."], "sentence_id": 6, "word_count": 38}, {"text": "finally , fda decides whether to approve the application .", "tokens": ["finally", ",", "fda", "decides", "whether", "to", "approve", "the", "application", "."], "sentence_id": 7, "word_count": 10}, {"text": "for drugs and biologics that address unmet needs or serious diseases or conditions , fda regularly uses three formal mechanisms to expedite the development and review process: fast track product development , priority review , and accelerated approval .", "tokens": ["for", "drugs", "and", "biologics", "that", "address", "unmet", "needs", "or", "serious", "diseases", "or", "conditions", ",", "fda", "regularly", "uses", "three", "formal", "mechanisms", "to", "expedite", "the", "development", "and", "review", "process", ":", "fast", "track", "product", "development", ",", "priority", "review", ",", "and", "accelerated", "approval", "."], "sentence_id": 8, "word_count": 40}, {"text": "this report briefly describes ( in text and in table 1 ) those mechanisms , including their intended effects and statutory and regulatory bases , and examines whether fast track accomplishes two goals: making approval more likely and shortening approval time .", "tokens": ["this", "report", "briefly", "describes", "(", "in", "text", "and", "in", "table", "1", ")", "those", "mechanisms", ",", "including", "their", "intended", "effects", "and", "statutory", "and", "regulatory", "bases", ",", "and", "examines", "whether", "fast", "track", "accomplishes", "two", "goals", ":", "making", "approval", "more", "likely", "and", "shortening", "approval", "time", "."], "sentence_id": 9, "word_count": 43}, {"text": "are products that receive fast track designation more likely to have their nda / bla approved by fda than products that receive no such designation ? .", "tokens": ["are", "products", "that", "receive", "fast", "track", "designation", "more", "likely", "to", "have", "their", "nda", "/", "bla", "approved", "by", "fda", "than", "products", "that", "receive", "no", "such", "designation", "?", "."], "sentence_id": 10, "word_count": 27}, {"text": "the answer is we don't know , because , while fda provides statistics on the products it designates as fast track , it does not make public information on the nda / blas it receives unless and until the product is approved / licensed .", "tokens": ["the", "answer", "is", "we", "do", "n't", "know", ",", "because", ",", "while", "fda", "provides", "statistics", "on", "the", "products", "it", "designates", "as", "fast", "track", ",", "it", "does", "not", "make", "public", "information", "on", "the", "nda", "/", "blas", "it", "receives", "unless", "and", "until", "the", "product", "is", "approved", "/", "licensed", "."], "sentence_id": 11, "word_count": 46}, {"text": "what we do know from material on the fda website: manufacturers have requested fast track designation for 569 drugs and 195 biological products since the fast track program was set into law .", "tokens": ["what", "we", "do", "know", "from", "material", "on", "the", "fda", "website", ":", "manufacturers", "have", "requested", "fast", "track", "designation", "for", "569", "drugs", "and", "195", "biological", "products", "since", "the", "fast", "track", "program", "was", "set", "into", "law", "."], "sentence_id": 12, "word_count": 34}, {"text": "fda granted the designation to 74.5% of those drug requests and 63.6% of those biologics requests .", "tokens": ["fda", "granted", "the", "designation", "to", "74.5", "%", "of", "those", "drug", "requests", "and", "63.6", "%", "of", "those", "biologics", "requests", "."], "sentence_id": 13, "word_count": 19}, {"text": "of products with fast track designation , fda eventually approved 10.6% of the drugs and licensed 17.7% of the biologics .", "tokens": ["of", "products", "with", "fast", "track", "designation", ",", "fda", "eventually", "approved", "10.6", "%", "of", "the", "drugs", "and", "licensed", "17.7", "%", "of", "the", "biologics", "."], "sentence_id": 14, "word_count": 23}, {"text": "what that means is obscured by what we do not know: for what percentage of products with fast track designation do sponsors submit nda / blas ? .", "tokens": ["what", "that", "means", "is", "obscured", "by", "what", "we", "do", "not", "know", ":", "for", "what", "percentage", "of", "products", "with", "fast", "track", "designation", "do", "sponsors", "submit", "nda", "/", "blas", "?", "."], "sentence_id": 15, "word_count": 29}, {"text": "how many nda / blas submitted each year are for fast track products ? .", "tokens": ["how", "many", "nda", "/", "blas", "submitted", "each", "year", "are", "for", "fast", "track", "products", "?", "."], "sentence_id": 16, "word_count": 15}, {"text": "with only the numerator ( approved products ) , one cannot calculate the percentage of nda / bla submissions that are approved among fast track products .", "tokens": ["with", "only", "the", "numerator", "(", "approved", "products", ")", ",", "one", "can", "not", "calculate", "the", "percentage", "of", "nda", "/", "bla", "submissions", "that", "are", "approved", "among", "fast", "track", "products", "."], "sentence_id": 17, "word_count": 28}, {"text": "fda receives approximately 100-130 applications a year , and has stated that \"close to 80 percent of all filed applications will eventually be approved. .", "tokens": ["fda", "receives", "approximately", "100-130", "applications", "a", "year", ",", "and", "has", "stated", "that", "``", "close", "to", "80", "percent", "of", "all", "filed", "applications", "will", "eventually", "be", "approved", ".", "."], "sentence_id": 18, "word_count": 27}, {"text": "the 10.6 and 17.7% figures for fast track are not a comparable statistic because they include the apparently large , but unquantified , number of product development attempts that manufacturers discontinue ( for safety problems , lack of effectiveness , business decisions , competing projects ) .", "tokens": ["the", "10.6", "and", "17.7", "%", "figures", "for", "fast", "track", "are", "not", "a", "comparable", "statistic", "because", "they", "include", "the", "apparently", "large", ",", "but", "unquantified", ",", "number", "of", "product", "development", "attempts", "that", "manufacturers", "discontinue", "(", "for", "safety", "problems", ",", "lack", "of", "effectiveness", ",", "business", "decisions", ",", "competing", "projects", ")", "."], "sentence_id": 19, "word_count": 48}, {"text": "a useful analysis would account for the percentage of fast track and non - fast track products of which fda is aware ( e.g. , that have inds ) that result in submitted nda / blas .", "tokens": ["a", "useful", "analysis", "would", "account", "for", "the", "percentage", "of", "fast", "track", "and", "non", "-", "fast", "track", "products", "of", "which", "fda", "is", "aware", "(", "e.g", ".", ",", "that", "have", "inds", ")", "that", "result", "in", "submitted", "nda", "/", "blas", "."], "sentence_id": 20, "word_count": 38}, {"text": "how long it takes from the time a sponsor applies for marketing permission to the moment fda makes its decision varies greatly .", "tokens": ["how", "long", "it", "takes", "from", "the", "time", "a", "sponsor", "applies", "for", "marketing", "permission", "to", "the", "moment", "fda", "makes", "its", "decision", "varies", "greatly", "."], "sentence_id": 21, "word_count": 23}, {"text": "the length matters to the sponsor and its stockholders , to potential consumers and healthcare providers , and to fda .", "tokens": ["the", "length", "matters", "to", "the", "sponsor", "and", "its", "stockholders", ",", "to", "potential", "consumers", "and", "healthcare", "providers", ",", "and", "to", "fda", "."], "sentence_id": 22, "word_count": 21}, {"text": "two factors contribute to longer review times: review staff constraints at fda , and the quality and completeness of applications when they are first submitted .", "tokens": ["two", "factors", "contribute", "to", "longer", "review", "times", ":", "review", "staff", "constraints", "at", "fda", ",", "and", "the", "quality", "and", "completeness", "of", "applications", "when", "they", "are", "first", "submitted", "."], "sentence_id": 23, "word_count": 27}, {"text": "pdufa and its three reauthorizations have addressed the staffing issue by authorizing industry user fees to support fda reviewers .", "tokens": ["pdufa", "and", "its", "three", "reauthorizations", "have", "addressed", "the", "staffing", "issue", "by", "authorizing", "industry", "user", "fees", "to", "support", "fda", "reviewers", "."], "sentence_id": 24, "word_count": 20}, {"text": "fda's web pages on the use of its fast track and priority review programs provide the review times for successful applications .", "tokens": ["fda", "'s", "web", "pages", "on", "the", "use", "of", "its", "fast", "track", "and", "priority", "review", "programs", "provide", "the", "review", "times", "for", "successful", "applications", "."], "sentence_id": 25, "word_count": 23}, {"text": "table 2 compares the review times , by year and type of review procedure , for all 787 approved nda / blas applications that were submitted from fy1998 through fy2006 .", "tokens": ["table", "2", "compares", "the", "review", "times", ",", "by", "year", "and", "type", "of", "review", "procedure", ",", "for", "all", "787", "approved", "nda", "/", "blas", "applications", "that", "were", "submitted", "from", "fy1998", "through", "fy2006", "."], "sentence_id": 26, "word_count": 31}, {"text": "these applications received either a standard review or a priority review , and the review times for these two procedures are summarized in the first two pairs of data columns in the table .", "tokens": ["these", "applications", "received", "either", "a", "standard", "review", "or", "a", "priority", "review", ",", "and", "the", "review", "times", "for", "these", "two", "procedures", "are", "summarized", "in", "the", "first", "two", "pairs", "of", "data", "columns", "in", "the", "table", "."], "sentence_id": 27, "word_count": 34}, {"text": "the third pair of columns summarizes review times for approved nda / bla applications for products that received a fast track designation .", "tokens": ["the", "third", "pair", "of", "columns", "summarizes", "review", "times", "for", "approved", "nda", "/", "bla", "applications", "for", "products", "that", "received", "a", "fast", "track", "designation", "."], "sentence_id": 28, "word_count": 23}, {"text": "as discussed below , most , though not all , of these 55 applications received a priority review and thus are counted in the priority review columns ; the remainder are captured in the standard review data .", "tokens": ["as", "discussed", "below", ",", "most", ",", "though", "not", "all", ",", "of", "these", "55", "applications", "received", "a", "priority", "review", "and", "thus", "are", "counted", "in", "the", "priority", "review", "columns", ";", "the", "remainder", "are", "captured", "in", "the", "standard", "review", "data", "."], "sentence_id": 29, "word_count": 38}, {"text": "the final pair of columns provide data on priority review times for ndas of new molecular entities ( nmes ) and new blas .", "tokens": ["the", "final", "pair", "of", "columns", "provide", "data", "on", "priority", "review", "times", "for", "ndas", "of", "new", "molecular", "entities", "(", "nmes", ")", "and", "new", "blas", "."], "sentence_id": 30, "word_count": 24}, {"text": "these applications represent a subset of all those subject to priority review , and are the group of products most similar to fast track products .", "tokens": ["these", "applications", "represent", "a", "subset", "of", "all", "those", "subject", "to", "priority", "review", ",", "and", "are", "the", "group", "of", "products", "most", "similar", "to", "fast", "track", "products", "."], "sentence_id": 31, "word_count": 26}, {"text": "each row of table 2 corresponds to approved applications submitted during a specific year .", "tokens": ["each", "row", "of", "table", "2", "corresponds", "to", "approved", "applications", "submitted", "during", "a", "specific", "year", "."], "sentence_id": 32, "word_count": 15}, {"text": "the total approval time includes the time fda spends to review an application , plus the time the sponsor takes to respond to questions , if necessary , plus the time fda spends on any additional review .", "tokens": ["the", "total", "approval", "time", "includes", "the", "time", "fda", "spends", "to", "review", "an", "application", ",", "plus", "the", "time", "the", "sponsor", "takes", "to", "respond", "to", "questions", ",", "if", "necessary", ",", "plus", "the", "time", "fda", "spends", "on", "any", "additional", "review", "."], "sentence_id": 33, "word_count": 38}, {"text": "the table provides the median approval time for each submission year group , which is the value at the mid - point of times in a group .", "tokens": ["the", "table", "provides", "the", "median", "approval", "time", "for", "each", "submission", "year", "group", ",", "which", "is", "the", "value", "at", "the", "mid", "-", "point", "of", "times", "in", "a", "group", "."], "sentence_id": 34, "word_count": 28}, {"text": "fda uses the median in its reports , stating , \"it provides a truer picture of our performance than average time , which can be unduly influenced by a few very long or short times. .", "tokens": ["fda", "uses", "the", "median", "in", "its", "reports", ",", "stating", ",", "``", "it", "provides", "a", "truer", "picture", "of", "our", "performance", "than", "average", "time", ",", "which", "can", "be", "unduly", "influenced", "by", "a", "few", "very", "long", "or", "short", "times", ".", "."], "sentence_id": 35, "word_count": 38}, {"text": "fast track submissions in theory differ from routine nda / bla submissions because they address unmet needs in the treatment of life - threatening or serious conditions .", "tokens": ["fast", "track", "submissions", "in", "theory", "differ", "from", "routine", "nda", "/", "bla", "submissions", "because", "they", "address", "unmet", "needs", "in", "the", "treatment", "of", "life", "-", "threatening", "or", "serious", "conditions", "."], "sentence_id": 36, "word_count": 28}, {"text": "similar criteria apply to drugs that fda gives priority review status .", "tokens": ["similar", "criteria", "apply", "to", "drugs", "that", "fda", "gives", "priority", "review", "status", "."], "sentence_id": 37, "word_count": 12}, {"text": "in fact , 80% of fast track nda approvals were also given priority review , as were all of the approved fast track blas .", "tokens": ["in", "fact", ",", "80", "%", "of", "fast", "track", "nda", "approvals", "were", "also", "given", "priority", "review", ",", "as", "were", "all", "of", "the", "approved", "fast", "track", "blas", "."], "sentence_id": 38, "word_count": 26}, {"text": "again , fda makes public detailed data only regarding the products that it approves / licenses .", "tokens": ["again", ",", "fda", "makes", "public", "detailed", "data", "only", "regarding", "the", "products", "that", "it", "approves", "/", "licenses", "."], "sentence_id": 39, "word_count": 17}, {"text": "using the data in table 2 to determine the impact fast track designation has on approval time is complicated by limitations in the data available .", "tokens": ["using", "the", "data", "in", "table", "2", "to", "determine", "the", "impact", "fast", "track", "designation", "has", "on", "approval", "time", "is", "complicated", "by", "limitations", "in", "the", "data", "available", "."], "sentence_id": 40, "word_count": 26}, {"text": "these include the following: inadequate data: available fda tables aggregate applications by year and present only the median approval time value for each year .", "tokens": ["these", "include", "the", "following", ":", "inadequate", "data", ":", "available", "fda", "tables", "aggregate", "applications", "by", "year", "and", "present", "only", "the", "median", "approval", "time", "value", "for", "each", "year", "."], "sentence_id": 41, "word_count": 27}, {"text": "this precludes using the individual application times in subsequent calculations .", "tokens": ["this", "precludes", "using", "the", "individual", "application", "times", "in", "subsequent", "calculations", "."], "sentence_id": 42, "word_count": 11}, {"text": "missing data: data available for analysis come from approved applications .", "tokens": ["missing", "data", ":", "data", "available", "for", "analysis", "come", "from", "approved", "applications", "."], "sentence_id": 43, "word_count": 12}, {"text": "inclusion of numbers of applications and total time to review decision ( approval or not ) would allow examination of additional aspects of the fast track program that may provide advantages that do not affect total approval time .", "tokens": ["inclusion", "of", "numbers", "of", "applications", "and", "total", "time", "to", "review", "decision", "(", "approval", "or", "not", ")", "would", "allow", "examination", "of", "additional", "aspects", "of", "the", "fast", "track", "program", "that", "may", "provide", "advantages", "that", "do", "not", "affect", "total", "approval", "time", "."], "sentence_id": 44, "word_count": 39}, {"text": "unavailable documentation of decisions: without detailed documentation of the many decisions embedded in the fda summary tables , accuracy or consistency in assignment to year of submission rather than year of approval cannot be assessed .", "tokens": ["unavailable", "documentation", "of", "decisions", ":", "without", "detailed", "documentation", "of", "the", "many", "decisions", "embedded", "in", "the", "fda", "summary", "tables", ",", "accuracy", "or", "consistency", "in", "assignment", "to", "year", "of", "submission", "rather", "than", "year", "of", "approval", "can", "not", "be", "assessed", "."], "sentence_id": 45, "word_count": 38}, {"text": "if an application is assigned to one year in the fast track column and to another in the all priority column , for example , relying on the annual median approval times could distort the comparisons .", "tokens": ["if", "an", "application", "is", "assigned", "to", "one", "year", "in", "the", "fast", "track", "column", "and", "to", "another", "in", "the", "all", "priority", "column", ",", "for", "example", ",", "relying", "on", "the", "annual", "median", "approval", "times", "could", "distort", "the", "comparisons", "."], "sentence_id": 46, "word_count": 37}, {"text": "overlapping categories: the all priority and all standard groups sum to the total number of approved applications in each submission year .", "tokens": ["overlapping", "categories", ":", "the", "all", "priority", "and", "all", "standard", "groups", "sum", "to", "the", "total", "number", "of", "approved", "applications", "in", "each", "submission", "year", "."], "sentence_id": 47, "word_count": 23}, {"text": "the other categories , however , overlap .", "tokens": ["the", "other", "categories", ",", "however", ",", "overlap", "."], "sentence_id": 48, "word_count": 8}, {"text": "by definition , the priority nmes and new blas category is a subset of the all priority ndas and blas .", "tokens": ["by", "definition", ",", "the", "priority", "nmes", "and", "new", "blas", "category", "is", "a", "subset", "of", "the", "all", "priority", "ndas", "and", "blas", "."], "sentence_id": 49, "word_count": 21}, {"text": "for the fast track ndas , at least 87% are counted in the priority nda group and at least 68% are also counted in the priority nme group .", "tokens": ["for", "the", "fast", "track", "ndas", ",", "at", "least", "87", "%", "are", "counted", "in", "the", "priority", "nda", "group", "and", "at", "least", "68", "%", "are", "also", "counted", "in", "the", "priority", "nme", "group", "."], "sentence_id": 50, "word_count": 31}, {"text": " ( fda lists some fast track nme applications as assigned to standard review. ) .", "tokens": ["(", "fda", "lists", "some", "fast", "track", "nme", "applications", "as", "assigned", "to", "standard", "review", ".", ")", "."], "sentence_id": 51, "word_count": 16}, {"text": "as expected , based on program goals , times are shorter for priority review than for standard review .", "tokens": ["as", "expected", ",", "based", "on", "program", "goals", ",", "times", "are", "shorter", "for", "priority", "review", "than", "for", "standard", "review", "."], "sentence_id": 52, "word_count": 19}, {"text": "for seven of the nine years , median fast track times were shorter than priority reviews , suggesting that fast track may have reduced time - to - market beyond the shortening of review time afforded by priority review .", "tokens": ["for", "seven", "of", "the", "nine", "years", ",", "median", "fast", "track", "times", "were", "shorter", "than", "priority", "reviews", ",", "suggesting", "that", "fast", "track", "may", "have", "reduced", "time", "-", "to", "-", "market", "beyond", "the", "shortening", "of", "review", "time", "afforded", "by", "priority", "review", "."], "sentence_id": 53, "word_count": 40}, {"text": "a more detailed analysis of individual application data might indicate how group differences may be due to obvious exceptions , different procedures or application completeness or quality , or unknown factors or chance .", "tokens": ["a", "more", "detailed", "analysis", "of", "individual", "application", "data", "might", "indicate", "how", "group", "differences", "may", "be", "due", "to", "obvious", "exceptions", ",", "different", "procedures", "or", "application", "completeness", "or", "quality", ",", "or", "unknown", "factors", "or", "chance", "."], "sentence_id": 54, "word_count": 34}, {"text": "for example , how does the wide range of approval times \u2014 from 2.4 to 34.1 months \u2014 for the eight fast track product nda / blas submitted in 2001 affect group averages ? .", "tokens": ["for", "example", ",", "how", "does", "the", "wide", "range", "of", "approval", "times", "\u2014", "from", "2.4", "to", "34.1", "months", "\u2014", "for", "the", "eight", "fast", "track", "product", "nda", "/", "blas", "submitted", "in", "2001", "affect", "group", "averages", "?", "."], "sentence_id": 55, "word_count": 35}, {"text": "finally , review time from submission to approval is only one measure of fast track effect .", "tokens": ["finally", ",", "review", "time", "from", "submission", "to", "approval", "is", "only", "one", "measure", "of", "fast", "track", "effect", "."], "sentence_id": 56, "word_count": 17}, {"text": "if a fast track designation enables a sponsor to submit a completed nda / bla sooner than it would otherwise , that advantage would not be evident in this comparison of review times that begins with submission .", "tokens": ["if", "a", "fast", "track", "designation", "enables", "a", "sponsor", "to", "submit", "a", "completed", "nda", "/", "bla", "sooner", "than", "it", "would", "otherwise", ",", "that", "advantage", "would", "not", "be", "evident", "in", "this", "comparison", "of", "review", "times", "that", "begins", "with", "submission", "."], "sentence_id": 57, "word_count": 38}], "section_names": ["", "mechanisms to expedite the development and review process", "measures of program effectiveness", "approval rates", "length of decision times for approval"], "section_lengths": [9, 0, 0, 11, 37]}